Vis enkel innførsel

dc.contributor.authorEikebrokk, Tuva
dc.contributor.authorVassmyr, Brita
dc.contributor.authorAusen, Kjersti
dc.contributor.authorGravastrand, Caroline S.
dc.contributor.authorSpigset, Olav
dc.contributor.authorPukstad, Brita
dc.date.accessioned2020-01-06T07:13:35Z
dc.date.available2020-01-06T07:13:35Z
dc.date.created2020-01-04T19:30:19Z
dc.date.issued2019
dc.identifier.citationBJS Open. 2019, 3 (6), 840-851.nb_NO
dc.identifier.issn2474-9842
dc.identifier.urihttp://hdl.handle.net/11250/2634885
dc.description.abstractBackground Topical administration of tranexamic acid (TXA) reduces bleeding from surgical wounds similarly to intravenous use, but with negligible risk of adverse systemic events. Topical use is expanding, but is off‐label. Surgeons lack guidelines regarding safe topical dosages and modes of administration. The effects of topical TXA on skin cells and wound healing are unknown. This study investigated whether topical TXA might be cytotoxic or affect wound re‐epithelialization. Methods Human keratinocytes and fibroblast cell cultures and an ex vivo human skin wound model were subjected to both short (limited) and long (chronic) exposure to various clinically relevant concentrations of TXA to mimic different modalities of topical administration. Cytotoxicity and effects on wound re‐epithelialization were evaluated. Results In cell culture, toxicity from chronic exposure was associated with increasing concentration and exposure time. Limited exposure to TXA did not cause significant cytotoxicity even at high concentrations. Re‐epithelialization was completely absent in wounds chronically exposed to TXA concentrations of 25 mg/ml or above, and 50–100 mg/ml induced epidermolysis of normal epithelium, possibly by a non‐toxic mechanism. Wound re‐epithelialization was slightly delayed, but not impaired, by limited exposure to 100 mg/ml or chronic exposure to 6·25 mg/ml. Conclusion Although short exposure to even high concentrations of topical TXA seems well tolerated in vitro, prolonged exposure can be cytotoxic and may affect wound re‐epithelialization. Surgeons should adjust the TXA concentration to the planned mode of topical administration in clinical practice.nb_NO
dc.language.isoengnb_NO
dc.publisherJohn Wiley & Sons Ltd on behalf of BJS Society Ltdnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleCytotoxicity and effect on wound re-epithelialization after topical administration of tranexamic acidnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber840-851nb_NO
dc.source.volume3nb_NO
dc.source.journalBJS Opennb_NO
dc.source.issue6nb_NO
dc.identifier.doi10.1002/bjs5.50192
dc.identifier.cristin1766293
dc.description.localcode© 2019 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.nb_NO
cristin.unitcode194,65,25,0
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for sirkulasjon og bildediagnostikk
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal